Lobe Sciences Announces Update on Corporate Slide Deck Highlighting its Psilocin Compounds and Development Plans Pharmaceutical Investing
Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy to Address Inequities in HIV Care Pharmaceutical Investing
Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio Pharmaceutical Investing
Love Pharma Announces Strategic Acquisition of Doc Hygiene Pharmaceuticals Inc. Pharmaceutical Investing
FDA Accepts Submission of Supplemental New Drug Application for LYNPARZA® in Combination With Abiraterone and Prednisone or Prednisolone for Patients With Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review Pharmaceutical Investing
Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics Pharmaceutical Investing
Merck and Orna Therapeutics Collaborate to Advance Orna's Next Generation of RNA Technology Pharmaceutical Investing
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study Pharmaceutical Investing
Knight Therapeutics Assumes Commercial Activities and Re-Launches Exelon in Brazil Pharmaceutical Investing
Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science Pharmaceutical Investing
